Tele-spirometry in Primary Care - Randomized Clinical Trial Cluster: the Effectiveness of Multifaceted Intervention in Symptoms Patients With Respiratory Illness
试验速览
- 阶段
- 不适用
- 入组人数
- 240
- 试验地点
- 1
- 主要终点
- Symptoms
研究概览
简要总结
The purpose of this study is to determine the effectiveness of telemedicine multifaceted intervention in symptoms patients with chronic obstructive pulmonary disease.
详细描述
This study is a randomized clinical trial for patients with chronic obstructive pulmonary disease from a primary care. The purpose is to determine the effectiveness of telemedicine (teleconsultation and telemonitoring) in control of chronic obstructive pulmonary disease symptoms.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Investigator)
入排标准
- 年龄范围
- 12 Years 至 100 Years（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •spirometry from TelessaudeRS-Universidade Federal do Rio Grande do Sul (from randomization cluster), Modified Medical Research Council Dyspnea > 0
排除标准
- •normal or restrictive spirometry, low quality spirometries (inadequate)
研究组 & 干预措施
Control
Spirometry in baseline Spirometry - 20 weeks
干预措施: Spirometry (Other)
Control
Spirometry in baseline Spirometry - 20 weeks
干预措施: Spirometry - 20 weeks (Other)
Intervention
Spirometry in baseline Teleconsultation Telemonitoring Spirometry - 20 weeks
干预措施: Spirometry (Other)
Intervention
Spirometry in baseline Teleconsultation Telemonitoring Spirometry - 20 weeks
干预措施: telemonitoring (Other)
Intervention
Spirometry in baseline Teleconsultation Telemonitoring Spirometry - 20 weeks
干预措施: teleconsultation (Other)
Intervention
Spirometry in baseline Teleconsultation Telemonitoring Spirometry - 20 weeks
干预措施: Spirometry - 20 weeks (Other)
结局指标
主要结局
Symptoms
时间窗: 20 a 22 weeks
Modified Medical Research Council Dyspnea Scale (difference in mMRC)
次要结局
- Spirometry - FEV1(20 a 22 weeks)
- Spirometry - FVC(20 a 22 weeks)